Enviva

This milestone stems from the companies' collaboration to expand access to affordable insulin to one million people living with diabetes in low- to middle-income c ountries annually by 2030 INDIANAPOLIS and CAIRO , Dec. 17, 2024 /PRNewswire/ -- The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with Eli Lilly and Company (NYSE: LLY). Launched in 2022, the collaboration aims to deliver a sustainable supply of high-quality, affordable human and analog insulin to at least one million people annually living with type 1 and type 2 diabetes in low- to middle-income countries (LMICs), most of which are in Africa.» Mehr auf prnewswire.com

I am bullish on Green Thumb Industries Inc. (GTBIF) due to its consistent revenue growth, strong balance sheet, and aggressive expansion efforts. GTBIF's revenue has grown YoY for seven quarters, despite turbulent profitability, driven by new store openings and market expansion. The company's strong balance sheet, low debt-to-equity ratio, and positive EVA indicate financial health and efficiency, supporting future growth.» Mehr auf seekingalpha.com

The addition of EVA Air advances Sabre's multi-source content strategy by expanding booking options for travel agencies SOUTHLAKE, Texas and SINGAPORE and TAIPEI CITY, Taiwan , Nov. 21, 2024 /PRNewswire/ --  Sabre Corporation  (NASDAQ: SABR), a leading software and technology provider that powers the global travel industry, today announced New Distribution Capability (NDC) connectivity from Star Alliance member and five-star SKYTRAX airline, EVA Air, through Sabre's global multi-source content platform. With this new connection, EVA Air's NDC content will be seamlessly integrated into Sabre's global distribution system (GDS), allowing travel agencies and corporate buyers to compare flight options with greater efficiency and transparency.» Mehr auf prnewswire.com